|
RBRC No. |
RBRC04347
|
|
Type |
Transgene |
 |
|
Species |
Mus musculus |
|
Strain name |
C57BL/6N-Tg(Wap-cre/Esr1)1Utr/Rbrc |
|
Former Common name |
No Data |
|
H-2 Haplotype |
No Data |
|
Background strain |
C57BL/6 |
|
Appearance |
| 1 |
Appearance |
No Data |
| Genotype |
No Data |
|
Strain development |
Developed by Laboratory Animal Resource Center, Tsukuba University and RIKEN BioResource Center in 2010. C57BL/6N background. |
|
Strain description |
Cre-driver transgenic mice. A transgenic construct containing sequence encoding Cre/Esr1 recombinase under the control of the mouse whey acidic protein promoter fragment (mammary gland cell specific promoter region) derived from the BAC library was microinjected into C57BL/6NCrlCrlj fertilized eggs. Tissue-specific expression of Cre recombinase has not been examined yet. Users are encouraged to test the tissue-specificity and feed back the data for the research community. |
|
Colony maintenance |
Carrier x Noncarrier [C57BL/6NCrlCrlj]. Hemizygous Tg mice are viable and fertile (viability and fertility of homozygotes are unknown). |
|
Animal health report |
No Data |
|
Gene Details |
|
Promoter |
No Data |
| 1 |
Symbol |
cre |
| Symbol name |
Phage P1 Cre recombinase |
| Chromosome |
No Data |
| Common name |
No Data |
| Symbol description |
No Data |
|
References |
No Data |
|
Research applications |
Cre/loxP system,
FLP/frt system |
|
Specific Term and Conditions |
The following terms and conditions will be requested by the DEPOSITOR.
In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to Dr. Ken-ichi Yagami, Laboratory Animal Resource Center, University of Tsukuba and RIKEN BioResource Center is requested. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. (will be announced) The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. |
|
Additional information |
|
1 |
No Data |
|
Depositor |
RIKEN, BioResource Center  |
|
Strain Status /
Availability
(Expected delivery) |
|
